Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tekiah McClary"'
Autor:
Anna M. Avinger, Hannah Claire Sibold, Gavin Campbell, Eli Abernethy, John Bourgeois, Tekiah McClary, Shannon Blee, Margie Dixon, R. Donald Harvey, Rebecca D. Pentz
Publikováno v:
BMC Medical Ethics, Vol 24, Iss 1, Pp 1-7 (2023)
Abstract Background Although patient advocates have developed templates for standard consent forms, evaluating patient preferences for first in human (FIH) and window of opportunity (Window) trial consent forms is critical due to their unique risks.
Externí odkaz:
https://doaj.org/article/e9e7fa6552c14fb687d7b39237c750ff
Autor:
Chineme Amechi, Lauren Ottenstein, Ayannah Lang, Tekiah McClary, Anna M. Avinger, Andre J. Burnham, Margie D. Dixon, Rebecca D. Pentz, Nicole C. Schmitt
Publikováno v:
Oral Oncology. 142:106434
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a02025b1fdf553263353e410382a12d9
https://doi.org/10.1016/j.oraloncology.2023.106434
https://doi.org/10.1016/j.oraloncology.2023.106434
Publikováno v:
JAMA Network Open. 5:e2236914
ImportanceEthical discussions have suggested that physicians who treat other physicians may put their physician-patients at risk of receiving non–standard-of-care treatment, which may result in worse outcomes. This phenomenon occurs when a physicia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b49ca2e06af1d5a090082d795873ead
https://doi.org/10.1001/jamanetworkopen.2022.36914
https://doi.org/10.1001/jamanetworkopen.2022.36914
Autor:
Anna Avinger, Hannah Claire Sibold, Gavin Paul Campbell, Eli Rowe Abernethy, John Bourgeois, Tekiah McClary, Shannon M. Blee, Margie D. Dixon, R. Donald Harvey, Rebecca D. Pentz
Publikováno v:
Journal of Clinical Oncology. 40:1562-1562
1562 Background: Although patient advocates have created templates for standard consent forms, assessing patient preferences for First in Human (FIH) and Window of Opportunity (WO) trials consents is important given their unique risks. FIH trials are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43b91e5fe563fdc1abbfb8ce6a01ff0a
https://doi.org/10.1200/jco.2022.40.16_suppl.1562
https://doi.org/10.1200/jco.2022.40.16_suppl.1562
Autor:
Tekiah McClary, Shannon M. Blee, Anna Avinger, Jeffrey M. Switchenko, Margie D. Dixon, Rebecca D. Pentz
Publikováno v:
Journal of Clinical Oncology. 40:12016-12016
12016 Background: Multiple myeloma (MM) is twice as common in African Americans (AA) as in Whites, yet AA make up only 5% of multiple myeloma (MM) clinical trial participants nationwide. Multiple studies have attempted to identify the reasons why AA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1090366f7ef36a9e3809b7c29af0164
https://doi.org/10.1200/jco.2022.40.16_suppl.12016
https://doi.org/10.1200/jco.2022.40.16_suppl.12016